Not applicableStudy completedNCT03200171What this trial is testingEffect of DAAs on Behavior of HCC in HCV PatientsWho this might be right forCarcinoma, HepatocellularHepatitis C Al-Azhar University 300
Testing effectiveness (Phase 2)Study completedNCT01058512What this trial is testingA Trial of NOV-205 in Hepatitis C Patients Who Failed Standard TherapyWho this might be right forHepatitis C Cellectar Biosciences, Inc. 22
Testing effectiveness (Phase 2)Study completedNCT03485846What this trial is testingEfficacy and Safety of All-Oral Combination of Narlaprevir/Ritonavir and Daclatasvir in Treatment-Naїve Patients With Chronic Hepatitis C Genotype 1bWho this might be right forChronic Hepatitis C Genotype 1b R-Pharm 105
Early research (Phase 1)Study completedNCT00828269What this trial is testingEvaluation of RNA From the Liver Tissue Obtained in Patients With Chronic Hepatitis C (0000-123)Who this might be right forChronic Hepatitis C Merck Sharp & Dohme LLC 12
Not applicableStudy completedNCT01054742What this trial is testingObservational Study of Patients With Chronic Hepatitis C Virus (HCV) Infected With HCV Genotype 1 Low Virus Load (LVL 1) and Effect of PegIntron Plus Rebetol Treatment (Study P04793 Part 2)Who this might be right forHepatitis C Merck Sharp & Dohme LLC 2
Post-approval studies (Phase 4)Ended earlyNCT03797066What this trial is testingATTIC - Access To Treat in the CommunityWho this might be right forHepatitis C, Chronic King's College Hospital NHS Trust 13
Testing effectiveness (Phase 2)Study completedNCT01628094What this trial is testingANNAPURNA: A Study of The Combination of RO5466731, RO5190591, Ritonavir and Copegus (Ribavirin) With or Without RO5024048 in Patients With Chronic Hepatitis C Who Are Either Treatment-Naïve or Have Previously Experienced a Null Response to Interferon-Based TreatmentWho this might be right forHepatitis C, Chronic Hoffmann-La Roche 110
Not applicableEnded earlyNCT01168856What this trial is testingAn Observational Study on Long-Term Persistence of Resistant Mutations And Durability of Sustained Virological Response in Patients With Chronic Hepatitis C Treated With Direct Acting Antiviral (DAA)- Containing RegimensWho this might be right forHepatitis C, Chronic Hoffmann-La Roche 734
Testing effectiveness (Phase 2)Study completedNCT00704405What this trial is testingSafety and Efficacy of Vaniprevir (MK-7009) With Pegylated Interferon (Peg-IFN) and Ribavirin (RBV) in Treatment-Experienced Hepatitis C Virus (HCV) Participants (MK-7009-009)Who this might be right forHepatitis C, Chronic Merck Sharp & Dohme LLC 285
Large-scale testing (Phase 3)Study completedNCT01343888What this trial is testingEfficacy and Safety of BI 201335 (Faldaprevir) in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-naïve Genotype 1 Hepatitis C Infected Patients (STARTverso 1)Who this might be right forHepatitis C Boehringer Ingelheim 656
Testing effectiveness (Phase 2)Study completedNCT01371578What this trial is testingOral Antivirals (GS-5885, Tegobuvir, and/or GS-9451) With Peginterferon Alfa 2a and Ribavirin in Treatment Experienced Subjects With Chronic Genotype 1 Hepatitis C Virus InfectionWho this might be right forHepatitis C, Chronic Gilead Sciences 163
Post-approval studies (Phase 4)Ended earlyNCT04515797What this trial is testingQUICKly Eradicate Hepatitis C in Patients Undergoing REnal Transplant With 4 Weeks of Glecaprevir/PibrentasvirWho this might be right forKidney FailureHepatitis CKidney Disease, Chronic Massachusetts General Hospital 2
Large-scale testing (Phase 3)Study completedNCT00215891What this trial is testingPEG-Interferon a-2b + Ribavirin for Treatment of Chronic HRN 005 Hepatitis C Infection in HIV-Infected Persons Not Previously Treated With InterferonWho this might be right forChronic Hepatitis C Infection in HIV-Infected PersonsHIV Infections Hepatitis Resource Network 300
Post-approval studies (Phase 4)Study completedNCT00056862What this trial is testingLow-Dose Peginterferon and Ribavirin to Treat Chronic Hepatitis C in Patients Infected With HCV Genotype 2 or 3Who this might be right forHepatitis C National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 58
Testing effectiveness (Phase 2)Study completedNCT00763568What this trial is testing4-Week Lead-In With Nitazoxanide Followed by 36 Weeks Nitazoxanide and Peginterferon Alfa-2a in Chronic Hepatitis CWho this might be right forChronic Hepatitis C Romark Laboratories L.C. 40
Testing effectiveness (Phase 2)Study completedNCT05091008What this trial is testingTreatment of Chronic Hepatitis C Infection by Ledipasvir/Sofosbuvir in Naïve ChildrenWho this might be right forHepatitis C, Chronic Mansoura University Children Hospital 50
Not applicableWithdrawnNCT01274013What this trial is testingVitamin D Deficiency in Subjects With Chronic Hepatitis C Compared to Healthy VolunteersWho this might be right forChronic Hepatitis C Avera McKennan Hospital & University Health Center
Post-approval studies (Phase 4)UnknownNCT00370617What this trial is testingPegylated-Interferon and Ribavirin Plus Metformin in the Treatment of Chronic HCV Infection and Insulin ResistanceWho this might be right forChronic Hepatitis CInsulin Resistance University of Turin, Italy 200
Not applicableUnknownNCT00956982What this trial is testingPEG-IFN Plus Ribavirin Combination Therapy for Older PatientsWho this might be right forHepatitis C Virus Kyushu University 1,251
Early research (Phase 1)Ended earlyNCT01554189What this trial is testingEvaluate the Safety, Pharmacokinetics and Pharmacodynamics of MK-8325 in Hepatitis C-Infected Males (MK-8325-002)Who this might be right forHepatitis C, Chronic Merck Sharp & Dohme LLC 37